Bacterial complications during pandemic influenza infection

Future Microbiology

Volumn 4, Issue 3, 2009, Pages 269-272

  Hussell, Tracy ^a   Wissinger, Erika ^a   Goulding, John ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; GAMMA INTERFERON; INTERLEUKIN 10; PROSTAGLANDIN E2; CELL ADHESION MOLECULE;

ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIAL SUPERINFECTION; BACTERIOLYSIS; COUGHING; CYTOKINE PRODUCTION; DYSPNEA; FEVER; HUMAN; INFLUENZA; LOW DRUG DOSE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; PROGNOSIS; SUPERINFECTION; ANIMAL; CIVIL DEFENSE; EPIDEMIC; EPITHELIUM CELL; LUNG; METABOLISM; MICROBIOLOGY; MOUSE; NASOPHARYNX; NOTE; ORTHOMYXOVIRUS; PATHOLOGY;

BACTERIA (MICROORGANISMS); ORTHOMYXOVIRIDAE;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CELL ADHESION MOLECULES; CIVIL DEFENSE; DISEASE OUTBREAKS; EPITHELIAL CELLS; HUMANS; INFLUENZA, HUMAN; LUNG; MICE; NASOPHARYNX; ORTHOMYXOVIRIDAE; PNEUMONIA, BACTERIAL;

EID: 65549137182     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.09.3     Document Type: Article

References (18)

1. Morens DM, Taubenberger JK, Fauci AS: Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198(7), 962-970 (2008).
2. Brundage JF, Shanks GD: Deaths from bacterial pneumonia during 1918-1919 influenza pandemic. Emerg. Infect. Dis. 14(8), 1193-1199 (2008).
3. Brundage JF: Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect. Dis. 6(5), 303-312 (2006).
4. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE: Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J. Clin. Invest. 38(1 Pt 2), 213-265 (1959).
5. Minino AM, Heron MP, Murphy SL, Kochanek KD: Deaths: final data for 2004. Natl Vital Stat. Rep. 55(19), 1-119 (2007).
6. McCullers JA: Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J. Infect. Dis. 190(3), 519-526 (2004).
7. McCullers JA, Bartmess KC: Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 187(6), 1000-1009 (2003).
8. Lee SE, Eick A, Bloom MS, Brundage JF: Influenza immunization and subsequent diagnoses of Group A Streptococcus-illnesses among USA Army trainees, 2002-2006. Vaccine 26(27-28), 3383-3386 (2008).
9. Medeiros AI, Serezani CH, Lee SP, Peters-Golden M: Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 206(1), 61-68 (2009).
10. Ren G, Su J, Zhao X et al.: Apoptotic cells induce immunosuppression through dendritic cells: critical roles of IFN-γ and nitric oxide. J. Immunol. 181(5), 3277-3284 (2008).
11. van der Sluijs KF, Nijhuis M, Levels JH et al.: Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J. Infect. Dis. 193(2), 214-222 (2006).
12. Sun K, Metzger DW: Inhibition of pulmonary antibacterial defence by interferon-γ during recovery from influenza infection. Nat. Med. 14(5), 558-564 (2008).
13. Didierlaurent A, Goulding J, Patel S et al.: Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205 (2), 323-329 (2008).
14. Karlstrom A, Boyd KL, English BK, McCullers JA: Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J. Infect. Dis. 199(3), 311-319 (2009).
15. Mandell LA, Wunderink RG, Anzueto A et al.: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44(Suppl. 2), S27-S72 (2007).
16. McCullers JA, English BK: Improving therapeutic strategies for secondary-bacterial pneumonia following influenza, Fut. Microbiol. 3, 397-404 (2008).
17. Regev-Yochay G, Raz M, Dagan R et al.: Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin. Infect. Dis. 38(5), 632-639 (2004).
18. Hirano T, Kurond Y, Ichimiya I, Suzuki M, Mogi G: Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization. Otolaryngol. Head Neck Surg. 121(5), 616-621 (1999).